Biogen Inc. and Genentech Inc. are heading to trial in June over a significant contract dispute concerning patent royalties ...

Screening tests are critical in early detection because they can find cancer before symptoms appear, when treatment is more ...

The US Food and Drug Administration (FDA) has approved bevacizumab-nwgd (Jobevne, Biocon Biologics Ltd), a biosimilar to bevacizumab (Avastin, Genentech), for intravenous use across multiple cancer ...

Moderate, heavy, and former heavy alcohol consumption are associated with hyaline arteriolosclerosis and neurofibrillary tangles, according to a study published online April 9 in Neurology. Alberto ...

Biocon Biologics has received the Food and Drug Administration’s green light for Jobevne (bevacizumab-nwgd), a biosimilar ...

A week after President Trump instituted broad tariffs on imports during his “Liberation Day,” he abruptly announced yesterday ...

The findings indicate that the currently approved 600-mg dose of intravenous ocrelizumab is optimal to significantly slow ...

Researchers used UK Biobank data to identify 70 proteins with genetically predicted roles in asthma, offering insights into ...

The SB221 trial was structured to evaluate the combination’s tolerability, pharmacodynamics, safety and pharmacokinetics.

Genentech announced that new data were presented at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data were presented at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases in ...

Convelo Therapeutics Inc. and Genentech Inc. have identified lanosterol 14α-demethylase (CYP51A1; CYP51) inhibitors reported to be useful for the treatment of multiple sclerosis, encephalomyelitis, ...